# Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation

> **NCT01653418** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Bortezomib
- **DRUG:** Carmustine
- **DRUG:** Etoposide
- **DRUG:** Cytarabine
- **DRUG:** Melphalan
- **PROCEDURE:** Stem cell infusion

## Key facts

- **NCT ID:** NCT01653418
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Due to the high rate of morbidity and mortality
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653418, "Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01653418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*